SUBSCRIBE
SUBSCRIBE

enVVeno Medical

IN THE PRESS
Press Releases
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
May 7, 2026
 · 
4 min read
Press Releases
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
April 29, 2026
 · 
6 min read
Press Releases
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
March 27, 2026
 · 
4 min read
Press Releases
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 5, 2026
 · 
2 min read
Press Releases
enVVeno Medical Announces Reverse Stock Split
January 16, 2026
 · 
4 min read
Press Releases
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
November 27, 2025
 · 
2 min read
Press Releases
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve
November 14, 2025
 · 
3 min read
Press Releases
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 31, 2025
 · 
4 min read
Press Releases
enVVeno Medical Updates Regulatory Status of VenoValve(R)
September 16, 2025
 · 
4 min read
Press Releases
enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)
August 20, 2025
 · 
4 min read
Load More
JOBS